KIP Global Pharma Private Equity Fund

Venture Capital

Sector-specific private equity fund by Korea Investment Partners targeting pharmaceuticals, semiconductors, and software investments in South Korea.

Seoul, South Korea · 4+ investments · 510 portfolio companies

Growth
Late Stage
Biotech
Healthcare
Semiconductors
Headquarters
Seoul, South Korea
Portfolio Companies
510
Total Investments
4
Last Investment
Jan 2016
Geographic Focus
Asia, South Korea

Investment Thesis

Sector-focused PE fund under Korea Investment Partners targeting Korean pharmaceutical and life sciences companies with diagnostics and medical businesses.

KIP Global Pharma Private Equity Fund is a Venture Capital firm based in Seoul, South Korea. It has made 4 investments in Biotech and Healthcare, including Elisigen, Philoptics and J&John.

Portfolio510

E
Elisigen
P
Philoptics
J
J&John
S
SkyLabs
SO
Studio Origin
Clarify
O
Ohmyhome
N
NeuroVenti
S
Sawnics
L
LinkGenesis
PT
Pin Therapeutics
RideFlux
QL
Quota Lab
FC
Future Connect
T
TribeX
T
TCUBEit
Wintec Glovis
SoFi
3
3Helix
Gencurix
GC
GL Chem
PI
Pharos iBio
S
SMLAB
B
BESTR
L
Labincube
Funda
KE
KY Entertainment
CM
Care Medi
L
LigaChemBio
P
Promedius
I
IMGT
FG
Friends Games
M
MinTech
A
ACTIVON
DK
Dstrict Korea
P
Ploonet
V
VSI
G
GuHaDa
T
theoneder
Atto Research
D&
Drama & Company
PT
Pinetree Therapeutics
Èlevit
BS
BlueStack Systems
MJ
Mighty Jaxx International Pte.
L
Lillem
L
Lessengers
RC
REVU Corporation

Investment History

Sign up to view investment history

Create a free account — 25 credits a month to unlock deal history, amounts, and round details.